By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

OncoCyte Corporation 

1301 Harbor Bay Parkway

Alameda  California  94502  U.S.A.
Phone: 510-521-3390 Fax: 510-521-3389


SEARCH JOBS


Industry
Biotechnology






Company News
Positive Clinical Results Of OncoCyte Corporation’s Panc-Dx Diagnostic Test Demonstrate High Level Of Sensitivity And Specificity In Non-Invasive Detection Of Bladder Cancer 4/20/2015 1:03:48 PM
OncoCyte Corporation Announces Initial Data From Ongoing Clinical Study Of Collagen Type X As A Marker And Potential Diagnostic For Breast Cancer And Other Types Of Human Cancers 4/20/2015 10:41:13 AM
OncoCyte Corporation Announces Availability Of Abstracts With New Clinical Data From Studies Of Panc-Dx Cancer Diagnostic In Bladder And Breast Cancer 3/20/2015 10:00:34 AM
OncoCyte Corporation To Present Cancer Diagnostic Clinical Study Data At American Association for Cancer Research Annual Meeting 2/6/2015 12:10:41 PM
BioTime (BTX) Subsidiary OncoCyte Corporation Appoints William Annett To Its Board Of Directors 1/12/2015 10:28:57 AM
BioTime (BTX) Subsidiary OncoCyte Corporation Completes Initial Enrollment Of Clinical Study Of Urine-Based Bladder Cancer Diagnostic 12/16/2014 11:48:21 AM
BioTime (BTX) Subsidiary OncoCyte Corporation Completes Initial Enrollment Of Clinical Study Of Urine-Based Bladder Cancer Diagnostic 12/15/2014 10:08:35 AM
BioTime (BTX)’s Subsidiary OncoCyte Corporation Announces Completion Of Multi-Site Clinical Study Of Lung Cancer Diagnostic By Collaborators At The Wistar Institute 10/3/2014 7:30:26 AM
BioTime (BTX)'s Subsidiary OncoCyte Corporation's CEO Dr. Joseph Wagner To Present At BTIG’s Inaugural “Emerging Technologies In Healthcare Diagnostics” Symposium 9/19/2014 8:28:40 AM
BioTime (BTX)'s Subsidiary OncoCyte Corporation And Abcodia To Collaborate On Breast Cancer Diagnostic Development 9/15/2014 11:00:54 AM
123
//-->